Immunophenotypical Analysis
| . | At Birth . | At 2.5 Months . | At 3 Months . | Healthy Controls (1 to 4 mo) . |
|---|---|---|---|---|
| PBL/μL | 3,026 | 4,253 | 8,890 | 4,100 ± 1,500 |
| CD3 (%) | 2 | 24 | 41 | 71 ± 7 |
| CD4 (%) | 2 | 24 | 41 | 40 ± 7 |
| CD8 (%) | 1 | 1 | 1 | 25 ± 5 |
| CD19 (%) | 79 | 48 | 44 | 18 ± 6 |
| CD16 (%) | 13 | 5 | 5 | 11 ± 5 |
| . | At Birth . | At 2.5 Months . | At 3 Months . | Healthy Controls (1 to 4 mo) . |
|---|---|---|---|---|
| PBL/μL | 3,026 | 4,253 | 8,890 | 4,100 ± 1,500 |
| CD3 (%) | 2 | 24 | 41 | 71 ± 7 |
| CD4 (%) | 2 | 24 | 41 | 40 ± 7 |
| CD8 (%) | 1 | 1 | 1 | 25 ± 5 |
| CD19 (%) | 79 | 48 | 44 | 18 ± 6 |
| CD16 (%) | 13 | 5 | 5 | 11 ± 5 |